Campbell & CO Investment Adviser LLC Buys 14,146 Shares of Integer Holdings Corporation $ITGR

Campbell & CO Investment Adviser LLC boosted its position in Integer Holdings Corporation (NYSE:ITGR) by 216.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,669 shares of the medical equipment provider’s stock after purchasing an additional 14,146 shares during the period. Campbell & CO Investment Adviser LLC owned about 0.06% of Integer worth $2,542,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. SVB Wealth LLC bought a new stake in shares of Integer in the first quarter valued at $35,000. CWM LLC grew its stake in shares of Integer by 46.1% during the 2nd quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 112 shares during the period. GAMMA Investing LLC increased its holdings in Integer by 20.2% in the 2nd quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider’s stock worth $98,000 after acquiring an additional 134 shares during the last quarter. Headlands Technologies LLC raised its stake in Integer by 1,234.8% in the 1st quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider’s stock valued at $145,000 after acquiring an additional 1,136 shares during the period. Finally, Quantbot Technologies LP bought a new stake in Integer in the 1st quarter valued at about $193,000. 99.29% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ITGR. Truist Financial reduced their target price on shares of Integer from $121.00 to $88.00 and set a “buy” rating for the company in a research note on Friday, October 24th. Benchmark reiterated a “hold” rating on shares of Integer in a research note on Friday, October 24th. Piper Sandler lowered their target price on shares of Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a report on Friday, October 24th. Citigroup cut their price target on Integer from $77.00 to $69.00 and set a “neutral” rating for the company in a report on Monday, November 3rd. Finally, Wells Fargo & Company reiterated an “equal weight” rating and set a $80.00 price objective (down from $132.00) on shares of Integer in a research note on Friday, October 24th. Four analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $96.75.

Integer Trading Up 2.4%

Integer stock opened at $68.24 on Monday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $146.36. The stock has a market cap of $2.39 billion, a P/E ratio of 28.55, a PEG ratio of 0.60 and a beta of 0.95. The firm’s fifty day moving average price is $95.47 and its 200-day moving average price is $108.90.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, topping the consensus estimate of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.The business’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.43 earnings per share. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Equities research analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Integer declared that its board has approved a share buyback plan on Tuesday, November 4th that permits the company to repurchase $200.00 million in outstanding shares. This repurchase authorization permits the medical equipment provider to reacquire up to 8.3% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.

Insider Transactions at Integer

In related news, CEO Payman Khales purchased 3,127 shares of the business’s stock in a transaction on Thursday, October 30th. The stock was acquired at an average price of $64.94 per share, with a total value of $203,067.38. Following the purchase, the chief executive officer directly owned 22,865 shares in the company, valued at approximately $1,484,853.10. This represents a 15.84% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 2.16% of the stock is currently owned by insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.